Abstract:
A novel pyrrolidinylamide ester derivative that exhibits inhibitory activity against prolyl endopeptidase, methods for synthesis thereof and its use as an inhibitor against said enzyme are disclosed. The pyrrolidinylamide ester of the invention has the following general formula: ##STR1## wherein n is 0 or an integer of 1 to 7 and R is hydrogen atom or a straight or branched alkyl having 1 to 8 carbon atoms.
Abstract:
A plant cultivation container includes a container body having: a plant cultivation space with an opening for planting a plant formed in a front face thereof; and a water reservoir portion for pooling plant cultivation water formed in a lower portion of the plant cultivation space, in which container a water-absorbing plant cultivation flooring material is mounted in the plant cultivation space so that a part of the plant cultivation flooring material is positioned inside the water reservoir portion. One of right and left walls of the container body disposed at right and left ends, respectively, of a front face of the container body is provided with an engaging portion, and the other of the right and left walls is provided with an engaged portion engageable with the engaging portion of another container body, such that a relative angle between two adjacent container bodies is changeable.
Abstract:
Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent for inflammatory bowel disease comprising at least one amino acid selected from the group consisting of lysine, histidine, phenylalanine, methionine, tryptophan, glutamine, glycine, cysteine, cystine and threonine, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day; and a TNF-α production inhibitor comprising an amino acid selected from the group consisting of histidine, phenylalanine and tryptophan, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day.
Abstract:
A method for preserving a cut flower involving only an easy and simple procedure, whereby the cut flower can maintain qualities similar to those of the natural state for a long period of time, and a method for manufacturing a processed cut flower that can maintain qualities similar to those of the natural state for a long period of time. The method for preserving a cut flower by replacing the tissue fluid of the cut flower by a preservative solution includes the steps of: (1) a first replacement step in which the tissue fluid of the cut flower is replaced by a hydrophilic organic solvent; and (2) a second replacement step in which the hydrophilic organic solvent having replaced the tissue fluid in the cut flower is replaced by the preservative solution of an organic solvent that has an affinity for the hydrophilic organic solvent and is nonvolatile or hardly-volatile.
Abstract:
The present invention provides an agent for the prophylaxis or treatment of visceral pain associated with gastrointestinal tract diseases, which contains lysine. Using the prophylactic or therapeutic agent, gastrointestinal tract diseases accompanying visceral pain, such as intestinal disorder, irritable bowel syndrome, functional dyspepsia, gastro esophageal disease, functional abdominal pain syndrome, ulcerative colitis and Crohn's disease and the like can be lo treated or prevented. In addition, pharmaceutical agent, food and drink and dietary supplement for the prophylaxis or treatment of visceral pain associated with such gastrointestinal tract diseases are provided. They are highly effective for visceral pain associated with gastrointestinal tract diseases as compared to existing pharmaceutical agents, show reduced side effects, and are highly effective.